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Objectives. This study sought to 1) compare the distribution of
extravascular (573 Da) and intravascular (92 kDa) magnetic
resonance (MR) contrast agents in reperfused infarcted myocar-
dium, and 2) investigate the effect of injury severity on these
distribution patterns.
Background. Myocardial distribution of low and high molecu-
lar weight contrast agents depends on vascular permeability,
diffusive/convective transport within the interstitium and accessi-
bility of the intracellular compartment (cellular integrity).
Methods. To vary the severity of myocardial injury, 72 rats were
subjected to 20, 30, 45 or 75 min (n 5 18, respectively) of coronary
artery occlusion. After 2 h of reflow, the animals received either
0.05 mmol/kg of gadolinium-diethylenetriaminepentaacetic acid-
bismethylamide (Gd-DTPA-BMA) (n 5 24), (Gd-DTPA)30-
albumin (n 5 24) or saline (control group, n 5 24). Three minutes
after injection, the hearts were excised and imaged (spin-echo
imaging parameters: repetition time 300 ms, echo time 8 ms,
2-tesla system), followed by triphenyltetrazolium chloride staining
for infarct detection and sizing.
Results. Histomorphometric and MR infarct size (expressed as
percent of slice surface) correlated well: r 5 0.96 for Gd-DTPA-
BMA; r 5 0.95 for (Gd-DTPA)30-albumin. On Gd-DTPA-BMA–
enhanced images, reperfused myocardial infarctions were homo-
geneously enhanced. The ratio of signal intensity of infarcted/
normal myocardium increased with increasing duration of
ischemia (overall p < 0.0001, analysis of variance [ANOVA]),
indicating an increase in the distribution volume of Gd-DTPA-
BMA in postischemic myocardium. On (Gd-DTPA)30-albumin–
enhanced images, reperfused infarctions consisted of a bright
border zone and a less enhanced central core. The extent of the
core increased with increasing duration of ischemia (overall p
value < 0.0001, ANOVA).
Conclusions. At 2 h of reperfusion, the distribution of MR
contrast agents in postischemic myocardium is 1) specific for
extravascular and intravascular agents, and 2) modulated by the
duration of ischemia.
(J Am Coll Cardiol 1997;30:1086–94)
©1997 by the American College of Cardiology
Revascularization procedures to restore impaired myocardial
blood supply in the setting of acute myocardial infarction find
their rationale in the assumption that at least some viable
myocardium is present in a flow-compromised territory. In this
context, intense work is still directed toward the development
of diagnostic techniques to assess myocardial viability.
On the basis of pathophysiologic studies, both myocardial
cell and microvascular damage is invoked as a possible marker
of myocardial infarction (1–5). A number of studies (6–18)
have assessed the capability of contrast-enhanced magnetic
resonance imaging (MRI) for the characterization of reper-
fused myocardial infarctions. Unlike intravascular contrast
agents, extravascular contrast agents distribute rapidly into the
extravascular space (19). Therefore, their distribution volume
may depend on 1) the size of the interstitial compartment, and
2) myocardial cell membrane integrity because myocytes with
loss of membrane integrity fail to exclude the extravascular
contrast agent from the intracellular compartment. In this
regard, it is possible that myocardial cell injury might be
evaluated by low molecular weight extravascular contrast
agents (6,20). In contrast, microvascular damage may be
probed by high molecular weight intravascular MR contrast
agents. Various enhancement patterns of reperfused infarcted
myocardium have been reported after the administration of
extravascular (6,7,9,11–13,15,21) and intravascular gadolinium
(Gd) chelates (10,16,17,22,23). To our knowledge, the use of
both types of contrast agents to more specifically characterize
ischemically damaged myocardium has not been attempted.
Accordingly, the current study was intended to 1) directly
compare the enhancement patterns induced by low molecular
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weight extravascular and high molecular weight intravascular
MR contrast agents in reperfused injured myocardium, and 2)
investigate the influence of injury severity on these different
enhancement patterns.
Methods
Animal preparation. The study was approved by the Com-
mittee on Animal Research at our institution. Seventy-two
Sprague-Dawley rats (Simonsen Labs, Inc.) weighing 250 to
320 g were anesthetized with an intraperitoneal injection of
sodium pentobarbital (50 mg/kg body weight). After tracheot-
omy, the animals were mechanically ventilated (Harvard Ap-
paratus Rodent Respirator). After left thoracotomy, the ante-
rior branch of the left main coronary artery was occluded using
a snare ligature (5-0 suture). The presence of occlusion was
confirmed by development of regional myocardial cyanosis.
The tail vein was cannulated (using a 27-gauge scalp vein
catheter) for administration of contrast agent and supplemen-
tal anesthetic.
Experimental protocol. The rats were subjected to 20, 30,
45 or 75 min of coronary artery occlusion (n 5 18 for each
occlusion period) (3,8,21,24). After completion of the occlu-
sion period, reperfusion was initiated by loosening the snare.
Myocardial reperfusion continued in all animals for 2 h before
imaging. Rats were divided into three groups receiving 1.0
ml/kg of either 1) extravascular contrast agent (Gd-
diethylenetriaminepentaacetic acid-bismethylamide [Gd-
DTPA-BMA], Omniscan at a dose of 0.05 mmol/kg); 2)
intravascular contrast agent [(Gd-DTPA)30-albumin at a dose
of 0.025 mmol/kg]; or 3) physiologic saline. Three minutes
later, all animals were killed by intravenous injection of 0.3 ml
of saturated solution of potassium chloride. The hearts were
excised and dabbed dry with gauze, and a cotton swab was
inserted into the left ventricular cavity through a small incision
in the left atrium to expand the left ventricular chamber. Each
heart was wrapped in clear plastic to minimize dehydration
during imaging.
Contrast agents. The longitudinal (T1) and transverse (T2)
relaxation times of the nonionic low molecular weight chelate
complex Gd-DTPA-BMA (molecular mass 573 Da) in water at
10 MHz (corresponding to a magnetic field strength of 0.25
tesla) at 37°C are 4.6 and 5.1 mmol/liter per s, respectively (25).
(Gd-DTPA)30-albumin (molecular mass 92 kDa) was prepared
according to Ogan et al. (26) and contained an average of 30
Gd-DTPA chelates that are covalently conjugated to human
serum albumin. For the (Gd-DTPA)30-albumin, the T1 and T2
relaxation times, as measured in water at 10 MHz at 37°C, were
15 and 22 mmol/liter per s per Gd31 ion, respectively (26).
MRI technique. All images were acquired using a Bruker
Omega 2.0-tesla system (Bruker Instruments, Inc.). Each heart
was positioned with its long axis parallel to the main magnetic
field such that axial images would represent short-axis views of
the heart. The midventricular level was defined on a horizontal
localizer as the midpoint of the long axis of the heart (between
the base and apex of the heart). Two axial (short axis) slices,
one below and one above the midventricular level, were
acquired using T1-weighted spin-echo imaging (repetition time
[TR] 300 ms, echo time [TE] 8 ms; slice thickness 2 mm; field
of view 30 mm 3 30 mm; data matrix 128 3 256 interpolated
to 256 3 256 during Fourier transformation; four acquisitions;
acquisition time 2.56 min). A previous report (27) showed high
correlation between infarction size as measured from all slices
of the heart compared with measurements derived from only
two midventricular slices in rats. Therefore, in the current
study, two midventricular slices were acquired, and all results
derived from these two slices are given as mean value of the
two slices.
Histochemical staining. After completion of the MRI ses-
sion, the heart was removed from the magnet. The midven-
tricular level was again defined (before removing the cotton
swab) as the midpoint of the long axis (between the base and
apex of the heart). The heart was then cut in half at the
midventricular level, and from each half a 2-mm thick slice of
the cut surface was obtained. The two slices were then soaked
in 2% solution of triphenyltetrazolium chloride (TTC) at 37°C
for 15 min. The TTC dye allows differentiation between viable
myocardium (brick red) and nonviable myocardium (un-
stained). A prerequisite for accurate detection and sizing of
myocardial infarction by TTC staining is sufficient time for
washout of reduced coenzymes from the infarcted tissue (28).
In pigs, where collateral circulation is as poor as that in rats, no
significant differences in infarction size were found when
measured with nitroblue tetrazolium after 2 and 24 h of
reperfusion, respectively (28). Therefore, in the present study
reperfusion was allowed for 2 h in all animals. The lower and
upper surface of each slice was photographed and scanned into
a MacIntosh computer. The sizes of red (viable) and unstained
(infarcted) myocardium were measured by planimetry (NIH
Image, version 1.59) and then expressed as a percentage of the
entire slice surface area.
MR image analysis. Measurement of infarction size. All
images were transferred to a SUN computer (SPARC 10, Sun
Microsystems), and image analysis was performed using anal-
ysis software (MRVision Co.). On contrast-enhanced images,
the extent of the enhanced region was determined by using a
threshold/signal intensity of normal myocardium plus 3 SD.
The signal intensity of normal myocardium was measured in a
Abbreviations and Acronyms
ANOVA 5 analysis of variance
Gd-DTPA-BMA 5 gadolinium-diethylenetriaminepentaacetic
acid-bismethylamide
MR 5 magnetic resonance
MRI 5 magnetic resonance imaging
ROI 5 region of interest
R1 5 longitudinal relaxation rates
TE 5 echo time
TR 5 repetition time
TTC 5 triphenyltetrazolium chloride
T1 and T2 5 longitudinal and transverse relaxation times
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region of interest (ROI) that was placed over the septum (2) of
the left ventricle (with the right ventricle used as a landmark)
and encompassed ;25% of the slice surface. The pixels with
intensities above the threshold were defined as representing
the infarcted region on MRI. These pixels were summed and
expressed as a percentage of the slice surface area.
Measurement of signal intensities in infarcted myocardium.
On the Gd-DTPA-BMA–enhanced images, the signal intensity
of the infarcted myocardium was derived from the entire
enhanced zone. On the (Gd-DTPA)30-albumin–enhanced im-
ages, the signal intensity was measured in two locations: the
hyperintense border of the infarcted zone (80 to 120 pixels)
and the core of the infarcted zone (50 to 100 pixels). In cases
where no dark core was observed (in four cases with 20 min of
occlusion time), an ROI (;50 pixels) was arbitarily located in
the center of the bright region. On unenhanced images (no
contrast agent administered), the infarcted region was not
identifiable as a hyperintense zone. To obtain a signal intensity
value of infarcted myocardium on unenhanced images, an ROI
(;100 pixels) was placed in the center of the infarcted
(unstained) myocardium according to TTC staining. In all rats,
myocardial signal intensity values were normalized to that of
an oil phantom, which was included in each imaging session.
Measurement of extent of central core. The size of the less
enhanced central core of the infarction on the (Gd-DTPA)30-
albumin–enhanced images was measured using the threshold/
signal intensity ratio of the hyperintense border zone minus 3
SD. All pixels of the infarcted region below this threshold were
counted and expressed as a percentage of the infarct size. On
images enhanced with Gd-DTPA-BMA, no less enhanced core
was observed. However, for comparison, the Gd-DTPA-BMA–
enhanced images were treated the same as the (Gd-DTPA)30-
albumin– enhanced images by measuring signal intensity in
the border of the enhanced zone to derive the threshold that
allowed calculation of hypointense pixels in the infarcted
zone.
Statistical analysis. Results are expressed as mean value 6
SEM. Between-group comparisons were performed using anal-
ysis of variance (ANOVA). If the analysis showed an overall
p , 0.05 value, the Scheffe´ test was implemented. For within-
heart comparisons (e.g., normal vs. infarcted myocardial re-
gions), ANOVA for repeated measures was used. Linear
regression analysis was used to compare infarction size defined
by histomorphometric analysis with that by MRI. A value of
p , 0.05 was considered significant.
Results
Myocardial infarction size. Infarction size as defined by
TTC staining did not differ among the three experimental
groups—Gd-DTPA-BMA, (Gd-DTPA)30-albumin and control
rats—at any given duration of coronary occlusion (two-way
ANOVA). However, infarction size increased significantly with
increasing duration of ischemia from 20 to 45 min (Fig. 1).
Longer ischemia (.45 min) did not produce a larger infarction
but was associated with macroscopic intramyocardial hemor-
rhage preferentially located in the center of the infarction.
Hemorrhagic areas were undetectable on unenhanced MR
images (no significant differences in signal intensity between
normal myocardium and the center of infarcted myocardium)
(Table 1), indicating that potential reduction of signal intensity
by deoxyhemoglobin (29) was not important for the short TE
setting used.
On Gd-DTPA-BMA–enhanced images, infarcted myocar-
dium was observed as a homogeneous hyperintense zone (Fig.
2). On (Gd-DTPA)30-albumin–enhanced images, infarcted
myocardium was observed as an inhomogeneously enhanced
zone, consisting of a hyperintense border zone that surrounded
a less enhanced core of variable extent depending on duration
of ischemia (Fig. 2). For these two groups of rats, the regres-
sion lines comparing infarct size on MR images and on TTC
stains were similar: slope 1.06 and 1.14, intercept 10.3% and
9.7% for Gd-DTPA-BMA– enhanced and (Gd-DTPA)30-
albumin–enhanced images, respectively (Fig. 3). Infarction
size was overestimated on contrast-enhanced MR images
compared with histomorphometric analysis.
Severity of myocardial injury: Gd-DTPA-BMA–enhanced
images. The signal intensity of unenhanced normal myocar-
dium (control group) ranged from 0.27 to 0.28 for the different
occlusion times and was significantly less than that of Gd-
DTPA-BMA–enhanced images, ranging from 0.41 to 0.42
(p , 0.0001, unpaired t test for each occlusion time) (Table 1).
Reperfused infarcted myocardium was visualized as a hyper-
intense region compared with normal myocardium (Fig. 2).
The signal intensity of the infarcted region increased with
increasing duration of ischemia (overall p value , 0.0001,
ANOVA), reaching a maximal level of 0.76 6 0.01 at 45 min
(Table 1). Similarly, the ratio of the signal intensity of
Figure 1. Infarction size as determined by histomorphometric analysis.
Bar graph representing the infarction size as defined by TTC staining
for the three experimental groups at the four different occlusion times
(n 5 6 for each group and occlusion time). The three groups did not
differ in infarction size for any given occlusion time (two-way
ANOVA). Infarction size increased with occlusion time up to 45 min.
*p , 0.0001 versus 20 min. #p , 0.0001 versus 30 min. Groups at each
occlusion time were pooled, and a one-way ANOVA was performed,
followed by a Scheffe´ test.
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infarcted/normal myocardium increased significantly (overall
p value , 0.0001, ANOVA) from 20 to 45 min of ischemia,
indicating an increase in the distribution volume of Gd-DTPA-
BMA in the infarcted region with increasing duration of
ischemia (Fig. 4). Quantitative analysis using a threshold of 3
SD below the signal intensity of the border zone yielded only
few hypointense pixels encompassing 3.5% to 5.5% of the
entire hyperintense region (Fig. 5). These hypointense pixels
were homogeneously scattered throughout the infarcted region
and did not form a hypointense core as in the (Gd-DTPA)30-
albumin–enhanced images (Fig. 2). The percent of hypoin-
tense pixels did not change with increasing occlusion times
(Fig. 5). The homogeneous enhancement of the reperfused
infarcted region on Gd-DTPA-BMA–enhanced images pro-
Figure 2. MRI of rat hearts after
administration of low and high mo-
lecular weight contrast agents. Rep-
resentative examples of rat hearts (ex
vivo T1-weighed spin-echo images,
TR/TE 300/8 ms) after administra-
tion of low molecular weight Gd-
DTPA-BMA (A to D) or high molec-
ular weight (Gd-DTPA)30-albumin
(E to H). Hearts were subjected to
increasing durations of ischemia
from 20 (A, E) to 30 (B, F), 45 (C, G)
and 75 min (D, H). On both Gd-
DTPA-BMA– and (Gd-DTPA)30-
albumin–enhanced images, extent of
myocardial infarction increased with
increasing duration of ischemia.
Note the homogeneous enhance-
ment of the reperfused infarcted
myocardium on Gd-DTPA-BMA–
enhanced images at all occlusion
times (A to D) compared with the
inhomogeneous enhancement pattern
on (Gd-DTPA)30-albumin–enhanced
images at longer occlusion times (F
to H). The less enhanced central core
expanded with increasing duration of
ischemia.
Table 1. Signal Intensity of Normal and Reperfused Infarcted Myocardium in the Three
Experimental Groups
Group*
Signal Intensity (mean 6 SEM)
20-min Ischemia 30-min Ischemia 45-min Ischemia 75-min Ischemia
Control (no contrast medium, n 5 6)
Normal myocardium 0.272 6 0.007 0.267 6 0.004 0.278 6 0.005 0.276 6 0.005
Infarcted myocardium 0.282 6 0.005 0.271 6 0.010 0.278 6 0.008 0.279 6 0.006
Gd-DTPA-BMA (n 5 6)
Normal myocardium 0.419 6 0.025 0.416 6 0.017 0.412 6 0.015 0.420 6 0.013
Infarcted myocardium 0.563 6 0.011 0.670 6 0.019† 0.756 6 0.012‡§ 0.753 6 0.028‡§
(Gd-DTPA)30-albumin (n 5 6)
Normal myocardium 0.356 6 0.009 0.358 6 0.010 0.354 6 0.018 0.373 6 0.013
Infarcted myocardium
Border 0.599 6 0.027 0.618 6 0.024 0.584 6 0.037 0.635 6 0.029
Core 0.566 6 0.037 0.510 6 0.030 0.446 6 0.033 0.485 6 0.043
*p , 0.03 for comparisons between respective zones in control and contrast-injected rats (unpaired Student t test
followed by Bonferroni correction). (Gd-DTPA)30-albumin 5 (gadolinium-diethylenetriaminepentaacetic acid)30-
albumin (normal vs. border of infarcted myocardium; overall p value , 0.0001, repeated measures analysis of variance
[ANOVA]; normal vs. core of infarcted myocardium; overall p value ,0.0001, repeated-measures ANOVA; effect of time
on signal intensity of border and core of infarcted myocardium was not significant [overall p values 0.35 and 0.15,
respectively, ANOVA]); Gd-DTPA-BMA 5 gadolinium-diethylenetriaminepentaacetic acid-bismethylamide (normal vs.
infarcted myocardium, overall p value ,0.0001, repeated-measures ANOVA; †p , 0.01 and ‡p , 0.0001 vs. infarction
myocardium subjected to 20 min of ischemia [ANOVA followed by Scheffe´ test]; §p , 0.05 vs. infarcted myocardium
subjected to 30 min of ischemia [ANOVA followed by Scheffe´ test]).
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vides evidence that the contrast agent was delivered to the
entire reperfused infarcted region, and homogeneous distribu-
tion was rapidly established (within the first 3 min after
injection) in the entire reperfused infarction.
Severity of myocardial injury: (Gd-DTPA)30-albumin–
enhanced images. On (Gd-DTPA)30-albumin–enhanced im-
ages, the infarcted region was essentially homogeneously en-
hanced in hearts subjected to 20 min of ischemia (Fig. 2). In
hearts subjected to longer duration of ischemia, the reperfused
infarcted region showed a hypoenhanced core (compared with
the hyperintense border zone). The extent of the hypoen-
hanced core increased from 2.6 6 1.5% of the infarcted region
in rats (n 5 6) subjected to 20 min of coronary artery occlusion
to 34.5 6 3.5% in those (n 5 6) subjected to 75 min of
occlusion (overall p value ,0.0001, ANOVA) (Fig. 5). The
signal intensity of the hyperintense border zone ranged from
0.58 to 0.63 and did not differ with increasing duration of
ischemia (Table 1). The signal intensities of both the border
zone and the less enhanced central core were higher than that
of normal myocardium at all occlusion times (Table 1), pro-
viding evidence that (Gd-DTPA)30-albumin was delivered to
the entire region of reperfused infarction.
Discussion
The principal findings of the current study can be summarized
as follows: 1) The extent of reperfused myocardial infarctions
can be quantified using low molecular weight (extravascular)
and high molecular weight (intravascular) MR contrast agents;
2) extravascular Gd-DTPA-BMA distributes homogeneously
within the reperfused infarcted myocardium, and its distribu-
tion volume increases with increasing duration of ischemia; 3)
intravascular (Gd-DTPA)30-albumin distributes inhomoge-
neously within reperfused infarcted myocardium with impaired
distribution in the central core of the infarction. The extent of
the central core expands with increasing duration of ischemia.
Extent of reperfused myocardial infarction. As shown in
previous studies (8,14) using low molecular weight Gd che-
lates, the size of myocardial infarction defined on contrast-
enhanced MR images was closely correlated with infarction
size defined by TTC histomorphometric analysis. The present
data are in agreement with these earlier reports because
Gd-DTPA-BMA–enhanced zones overestimated true infarc-
tion size by ;10% of left ventricular slice area (6% to 12% in
Figure 3. Infarction size: histomorphometric analysis versus MRI.
Relation of infarction size on TTC staining and Gd-DTPA-BMA– and
(Gd-DTPA)30-albumin–enhanced T1-weighted MRI. Note the close
correlation with histomorphometric infarction size [r 5 0.96 for
Gd-DTPA-BMA; r 5 0.95 for (Gd-DTPA)30-albumin]. The slope of
the regression line (least-square fit) is close to 1 for both contrast
agents. Infarction size on contrast-enhanced MR images overestimates
true infarct size by ;10%.
Figure 4. Relation between changes in signal intensity ratio and
duration of ischemia. Graph demonstrating the effect of ischemia
duration (i.e., severity of injury) on signal intensity ratio (infarcted/
normal myocardium). On Gd-DTPA-BMA–enhanced images, signal
intensity ratio increases steadily with occlusion times up to 45 min
(*p , 0.0001 vs. 20 min; #p , 0.04 vs. 20 min; †p , 0.03 vs. 30 min,
ANOVA followed by Scheffe´ test). In the control group (no contrast
agent), signal intensity ratio does not change with increasing duration
of ischemia.
Figure 5. Differences in distribution of high and low molecular weight
contrast agents in relation to duration of ischemia. Graph demonstrat-
ing the effect of ischemia duration on the extent of hypointense areas
within the enhanced zone of reperfused infarcted myocardium. On
(Gd-DTPA)30-albumin–enhanced images, the extent of the less en-
hanced central core increases steadily with increasing occlusion times
(*p , 0.0001 vs. 20 min; #p , 0.01 vs. 20 min; †p , 0.01 vs. 30 min,
ANOVA followed by Scheffe´ test), whereas the portion of hypointense
pixels on Gd-DTPA-BMA–enhanced images is small and shows no
relation to occlusion time.
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earlier studies). This overestimation may be caused by inter-
stitial edema surrounding the infarcted territory. Other inves-
tigators (30,31) found a slight underestimation of infarct size of
2.9% to 4.4% of left ventricular slice area when measured with
TTC compared with histological analysis. It is thought that the
microscopic heterogeneity at the infarct margins can cause
underestimation of the TTC unstained area. Between the
TTC-defined infarction size and (Gd-DTPA)30-albumin–
enhanced zones, a similar correlation was found that also
overestimated true infarction size by ;10%. In the present
study the size of reperfused myocardial infarctions increased
up to an occlusion time of 45 min. This finding is in accordance
with results reported by Hale et al. (3). In rats subjected to
different durations of coronary artery occlusion and 24 h of
reperfusion, small infarctions were observed after 20 min of
ischemia, and infarction size did not increase further with
occlusion times .40 min. In another study (2), electron
microscopy revealed irreversible cell injury in rat myocardium
having had as little as 10 min of ischemia.
Severity of myocardial injury. In myocardial infarction,
myocyte necrosis is associated with the loss of microvascular
integrity (1,5). Because low molecular weight (extravascular)
Gd-based MR contrast agents are excluded from intact cells,
an increase in the distribution volume of these agents may
reflect loss of myocardial cell membrane integrity (6,20). In
contrast, leakage of the high molecular weight (intravascular)
(Gd-DTPA)30-albumin may indicate microvascular damage
(16,22). To study the relation between myocardial cell and
microvascular damage in postischemic myocardium, the distri-
bution patterns of low and high molecular weight MR contrast
agents were analyzed in reperfused infarcted myocardium
subjected to increasing durations of ischemia.
In the absence of contrast agents (control rats), reperfused
myocardial infarction was undetectable, and the entire myo-
cardium (normal and infarcted regions) was homogeneous
with respect to signal intensity. This finding is explained by the
small increase in T1 of postischemic myocardium in rats (20)
and the fact that the short TE is relatively insensitive to
potential changes in T2 (29). Thus, differences in the enhance-
ment pattern between Gd-DTPA-BMA– and (Gd-DTPA)30-
albumin–enhanced images are likely to be caused by differ-
ences in the physiologic distribution of the different sized
contrast agents. Furthermore, the three experimental groups
did not differ with respect to the size of infarcted areas, as
defined by histomorphometric analysis (Fig. 1).
Distribution of Gd-DTPA-BMA in reperfused infarcted
myocardium. On Gd-DTPA-BMA–enhanced images, the in-
jury zone showed greater signal intensity than normal myocar-
dium, and this differential increased with increasing duration
of myocardial ischemia. Greater signal intensity in postisch-
emic myocardium implies that more contrast agent is present
than in normal myocardium. Earlier studies reported higher
concentrations of extravascular Gd chelates in reperfused
infarcted myocardium of rats (32) and dogs (18). The primary
cause of elevated Gd-DTPA-BMA content in the injured
region is an enlarged tissue distribution volume. Two causes of
enlarged distribution volume are interstitial edema (21,33) and
cellular necrosis (6,20,33). Gd-DTPA-BMA is excluded from
viable myocytes, but damage to the myocyte membrane during
ischemia/reperfusion results in loss of cellular exclusion of
contrast agent.
The increased distribution volume in the injured region can
be estimated from quantitative evaluation of signal increase if
the contrast agent is in equilibrium phase distribution. Previ-
ous work (20) with this model suggest that this is true within
minutes of injection of contrast agent. Then, the relative
distribution volume of contrast agent in the tissue can be
estimated from the relative change (D) in the longitudinal
relaxation rate (R1) (DR1 5 1/T1 before contrast administra-
tion 2 1/T1 after contrast administration). In that study,
fractional distribution volumes in normal and reperfused in-
farcted myocardium were 0.24 and 0.98, respectively. The
distribution volume fraction of 0.98 for reperfused infarcted
myocardium indicates that essentially the entire population of
myocytes in the infarcted tissue failed to exclude the contrast
agent. In dogs subjected to 2 h of ischemia (and variable
duration of reperfusion), Pereira et al. (6) found a high
negative correlation between a viability marker (201thallium
uptake) and myocardial regions with elevated signal intensity
after Gd-DTPA.
In the present study, this concept of change in fractional
distribution volume of a low molecular weight contrast agent
reflecting myocardial cell damage was tested in hearts sub-
jected to different durations of ischemia. Because increasing
duration of ischemia is associated with progressive myocardial
cell damage (3,5,24,33,34), it can be speculated that increase in
signal intensity reflects an increase in the distribution volume
of Gd-DTPA-BMA. From the signal intensity data of the
present study (Table 1), DR1 values for different myocardial
regions can be calculated using the equation:
DR1 5 $ln@0.72 p SIpre/~SIpre 2 0.28 p SIpost!#%/0.3,
where SIpre and SIpost 5 precontrast and postcontrast myocar-
dial signal intensity, respectively. These calculations are based
on an assumed precontrast myocardial T1 of 0.9 (20), and
dipolar T2 enhancement is neglected.
The ratio DR1infarcted myocardium/DR1normal myocardium would
then provide an estimate of the relative contrast agent concen-
tration in the infarcted myocardium. These calculations yield
DR1 ratios of approximately 2, 4, 5 and 5 for reperfused
myocardium subjected to 20, 30, 45 and 75 min of ischemia,
respectively, consistent with an increase in fractional distribu-
tion volume of contrast agent with increasing severity of
ischemia. Histologic and electron microscopic studies in rats
showed that irreversibly and reversibly damaged myocytes may
reside next to each other in the same infarct territory (2,34)
and that each of these cells may vary with respect to degree and
extent of alteration of its subcellular components (2). These
findings, and the fact that these changes depend on the
duration of ischemia (2) and reperfusion (35), may have
implications as to the interpretation of changes in the frac-
tional distribution volume of Gd-DTPA-BMA in infarcted
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reperfused myocardium. The lower distribution volumes for
the 20- and 30-min occlusion groups compared with the 45-
and 75-min occlusion groups indicate that cell membrane
damage is less severe in the short-occlusion groups. Because
this statement is true only at 2 h after reperfusion, it does not
necessarily imply a better prognosis for the short-occlusion
groups with respect to the fraction of intact cells that ultimately
will survive the ischemic challenge. It cannot be ruled out that
subcellular components in already irreversibly damaged myo-
cytes would still exhibit membrane integrity after 2 h of
reperfusion, thereby limiting the access of Gd-DTPA-BMA to
the entire intracellular space. Serial MRI in vivo studies during
reperfusion would allow definition of the time point when
disintegration of subcellular compartmentalization is com-
pleted and may provide prognostic information.
Furthermore, reperfused infarcted myocardium exhibited a
homogeneous enhancement after administration of Gd-
DTPA-BMA, irrespective of the duration of ischemia. Figure 5
illustrates this finding more quantitatively, showing the very
low percentage of hypointense pixels (3.5% to 5.5% of the
infarcted region, consistent with Gaussian distribution of pixel
values) that did not change with increasing occlusion times.
This finding provides evidence that the fraction of damaged
myocytes is distributed homogeneously (at the imaging reso-
lution used) rather than clumped within the infarcted zone.
This apparent homogeneity seen with MRI is in agreement
with a histologic study (34) that found severely damaged
myocytes homogeneously scattered throughout reperfused rat
myocardium subjected to various durations of anoxic perfu-
sion/reoxygenation.
Distribution of (Gd-DTPA)30-albumin in reperfused in-
farcted myocardium. On (Gd-DTPA)30-albumin–enhanced
images, a homogeneous enhancement of infarcted myocar-
dium was seen only with an ischemia time of 20 min. With a
longer duration of ischemia, an inhomogeneous enhancement
pattern in the reperfused infarcted myocardium developed,
consisting of a bright border zone and a less enhanced central
core that showed progressive expansion with increasing dura-
tion of ischemia (Fig. 2 and 5). This observation is in concert
with reports from Lim et al. (16,17) who used another high
molecular weight Gd chelate (Gd-DTPA-polylysine) in cats.
They found a homogeneous enhancement of small myocardial
infarctions and an inhomogeneous enhancement pattern in
larger infarctions consisting of a bright border and a dark core.
Enhancement of reperfused infarcted myocardium on (Gd-
DTPA)30-albumin–enhanced images can be explained by the
loss of vascular integrity as a consequence of ischemia and
reperfusion. Functional studies of microvascular permeability
indicated that ischemia of as short as 15 to 20 min caused
substantial increase in protein extravasation in rats (36) and
dogs (4). Increased microvascular leakage would result in
higher concentrations of (Gd-DTPA)30-albumin in the in-
farcted tissue. Once the (Gd-DTPA)30-albumin molecules
reside in the edematous extravascular space, they gain access
to a large water pool that further contributes to signal en-
hancement.
The finding of a homogeneous enhancement of reperfused
infarcted myocardium on Gd-DTPA-BMA–enhanced images
for all occlusion times is indicative that the contrast agent is
delivered and distributed homogeneously within the entire
myocardial infarction, regardless of the duration of ischemia.
As with Gd-DTPA-BMA, it seemed reasonable to assume that
(Gd-DTPA)30-albumin would also be delivered to the entire
myocardial infarction. However, enhancement of the infarcted
myocardium was inhomogeneous, with a less enhanced core in
the center of the infarction (Fig. 2, Table 1). This pattern of
contrast agent distribution in reperfused infarcted myocardium
was confirmed histologically using biotin-labeled (Gd-
DTPA)30-albumin in combination with immunohistochemical
staining (22). Distribution of contrast agent in the tissue
depends not only on its delivery (perfusion), but also on the
traversal of the contrast agent across the capillary wall and the
mixing of the contrast agent within the interstitium. Transport
of molecules across the capillary membrane and thereafter
within the interstitium is due to random thermal motion
(diffusion) and the motion of bulk fluid (convection) (37–40).
Transport of large molecules, such as albumin, is predomi-
nantly driven by convective forces that are governed by pres-
sure gradients. After a relative short period of ischemia (e.g.,
20 min) sufficient to cause functional vascular damage (4,36),
(Gd-DTPA)30-albumin, mainly driven by the transcapillary
pressure gradient, permeates the capillary wall (39). After
severe, long-term ischemia (e.g., 45 and 75 min), severe
interstitial edema and elevated tissue pressure may develop
in the center of reperfused infarctions (4,21,33,36,39). The
(Gd-DTPA)30-albumin delivered to that zone would encounter
a low transcapillary pressure gradient, and leakage driven by
convective forces would be reduced. Because transport of low
molecular weight compounds is mainly driven by diffusion,
Gd-DTPA-BMA would be expected to move across the capil-
lary wall and mix within the interstitium, irrespective of
variations in tissue pressure (37,38,41).
In the present study, animals were killed 3 min after
contrast agent administration. Studies in the same animal
model demonstrated that this time point is far beyond first-
pass conditions (21) and close to equilibrium phase distribu-
tion (20). Therefore, the enhancement patterns of reperfused
infarcted myocardium observed 3 min after contrast agent
injection mainly reflect tissue distribution of contrast agent
rather than its delivery (perfusion). Our data provide evidence
that Gd-DTPA-BMA is homogeneously distributed in the
reperfused infarcted myocardium (3 min after injection), and
its distribution is unaffected by possible perfusion inhomoge-
neities (no-reflow phenomenon) (42,43). Consequently, perfu-
sion inhomogeneities are unlikely to cause the inhomogeneous
distribution of (Gd-DTPA)30-albumin that was observed in the
reperfused infarcted myocardium.
First-pass versus equilibrium phase contrast agent distri-
bution. MRI in combination with low molecular weight con-
trast agents has been used in patients to assess the extent and
perfusion of myocardial infarction after intravenous thrombol-
ysis or percutaneous transluminal coronary angioplasty
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(11,12,15). Lima et al. (15) used a dynamic MRI approach in
combination with a low molecular weight Gd chelate to
monitor different enhancement patterns over time in patients
after revascularization procedures. A homogeneous enhance-
ment pattern was observed in successfully reperfused infarc-
tions, whereas in cases of a (re)occluded infarct-related artery,
hypointense areas within the enhanced region of myocardial
infarction were detected. In this context, the fundamental
differences between the two currently used MRI approaches
for the assessment of myocardial infarction should be empha-
sized. With a dynamic approach, myocardial transit of contrast
agent during first-pass conditions is measured to assess myo-
cardial perfusion (15,21,44–46). With the approach presented
in the present report, fractional distribution volumes for an
extravascular contrast agent are measured to assess cell mem-
brane integrity (6,20,47). During the first pass of contrast agent
through infarcted hypoperfused myocardium, this territory
would exhibit hypoenhancement due to delayed delivery of the
contrast agent (hypoperfusion), whereas the same territory
during equilibrium phase distribution would exhibit hyperen-
hancement due to an increased fractional distribution volume
of the extravascular contrast agent (loss of cell membrane
integrity). In addition to perfusion information, the results of
the current study and others (6,20) suggest that MRI in
combination with a low molecular weight contrast agent offers
the possibility of assessing contrast agent distribution volumes
that may reflect cell membrane integrity. Intravascular MR
contrast agents are now under development for clinical usage.
The findings described in the present report may be helpful in
interpreting clinical studies in the future.
Conclusions. Both extravascular and intravascular contrast
agents allow identification and quantification of reperfused
infarcted myocardium. However, the mechanisms that govern
contrast agent distribution are different for the two contrast
agents. As a consequence, contrast medium distribution depends
on the underlying tissue damage (i.e., myocyte or microvascular
injury). Extravascular Gd-DTPA-BMA provides a homogeneous
enhancement of the injury zone; increase in signal intensity with
increasing severity of injury may be related to progressive myo-
cardial cell damage. Intravascular (Gd-DTPA)30-albumin pro-
vides inhomogeneous enhancement of the injury zone; its distri-
bution within the injury zone may be impaired by elevated tissue
pressure. Increasing size of the less enhanced core may reflect
increasing severity of injury. Further studies are needed to
investigate the underlying mechanisms responsible for the differ-
ent distribution patterns described in the present report.
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